Study of the Safety of QRH-882260 Heptapeptide
NCT02574858
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Healthy Adults
Interventions
DRUG:
QRH-882260
Sponsor
University of Michigan